Key Events This Week
Feb 16: Reports flat quarterly performance amid margin pressures
Feb 16: Q3 FY26 losses deepen as other income turns sharply negative
Feb 18: Downgraded to Sell amid flat financials and mixed technical signals
Feb 20: Week closes at Rs.42.70 (-10.80%)

Vaxfab Enterprises Downgraded to Sell Amidst Flat Financials and Mixed Technical Signals
2026-02-18 08:27:10Vaxfab Enterprises Ltd, a player in the Trading & Distributors sector, has seen its investment rating downgraded from Hold to Sell following a comprehensive reassessment of its financial performance, valuation metrics, technical indicators, and overall quality scores. The downgrade reflects a shift in the company’s financial trend from positive to flat, coupled with mixed technical signals and valuation concerns despite strong long-term sales growth and return on capital employed.
Read full news article
Vaxfab Enterprises Q3 FY26: Losses Deepen as Other Income Turns Sharply Negative
2026-02-16 14:06:01Vaxfab Enterprises Limited, a micro-cap fabric and garment trader with a market capitalisation of ₹60.00 crores, reported deepening losses in Q3 FY26 (October-December 2025), posting a consolidated net loss of ₹3.24 crores compared to a profit of ₹6.41 crores in the year-ago quarter. The stock tumbled 9.99% to ₹43.09 following the results announcement, as investors reacted to the sharp deterioration in profitability driven by an unusual ₹3.37 crores negative other income charge. Despite revenue growing 9.28% year-on-year to ₹15.66 crores, operating performance weakened significantly, with operating profit margin contracting to just 2.04% from 13.92% in Q3 FY25.
Read full news article
Vaxfab Enterprises Ltd Reports Flat Quarterly Performance Amid Margin Pressures
2026-02-16 11:00:28Vaxfab Enterprises Ltd, a player in the Trading & Distributors sector, has reported a flat financial performance for the quarter ended December 2025, signalling a notable shift from its previously positive growth trajectory. Despite robust net sales growth and a strong return on capital employed (ROCE), the company’s profitability metrics have deteriorated sharply, raising concerns about margin pressures and operational efficiency.
Read full news articleAre Vaxfab Enterprises Ltd latest results good or bad?
2026-02-14 19:59:32Vaxfab Enterprises Ltd's latest financial results indicate a complex operational landscape characterized by significant revenue growth alongside challenges in profitability. In the first half of FY26, the company reported net sales of ₹69.61 crores, marking a record high for the firm. However, this revenue surge was accompanied by a consolidated net loss of ₹2.25 crores in Q2 FY26, representing a notable shift from previous profitable quarters. The financial performance illustrates a dramatic transformation in scale, with net sales for Q1 FY23 at just ₹4.15 crores, contrasting sharply with the current figures. The volatility in profitability is evident, as the company has experienced substantial fluctuations in operating margins, which have ranged from 2.09% to 30.77% in recent quarters. This inconsistency raises questions about the company's ability to manage costs and sustain its business model effective...
Read full news article








